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Liquefaction is one of the most intriguing aspects of human tuberculosis. It is a major cause of the transition from the infection
to active disease (tuberculosis, TB) as well as the transmission of M. tuberculosis to other persons. This paper reviews the natural
history of liquefaction in humans from a pathological and radiological point of view and discusses how the experimental models
available can be used to address the topic of liquefaction and cavity formation. Diﬀerent concepts that have been related to
liquefaction, from the inﬂuence of immune response to mechanical factors, are reviewed. Synchronic necrosis or apoptosis of
infected macrophages in a close area, together with an ineﬀective ﬁbrosis, appears to be clue in this process, in which macrophages,
the immune response, and bacillary load interact usually in a particular scenario: the upper lobes of the lung. The summary would
be that even if being a stochastic eﬀect, liquefaction would result if the organization of the intragranulomatous necrosis (by means
of ﬁbrosis) would be disturbed.
1. Liquefaction of Necrotic Tissue Takes
Place inthe Upper Lobes inHumans
1.1. The Primary Infection Is Usually Not Seen. Primary
infection is sometimes associated with Ghon’s Complex, that
is, the presence of a small lesion in the parenchyma, together
with enlarged hilar lymph nodes. The primary infection,
(about 0.5mm of diameter in average) is not detected by
the radiologist in around 85% of cases [1]. These lesions
have been described as nodular-acinar due to their size
and location in the bronchial tree, and from a histological
point of view, they are granulomas and characterized by the
induction of well-encapsulated central necrosis (or caseum)
[2].Suchlesionsbeingusuallyfoundinnecropsiesofsubjects
without any evidence of active TB. They are commonly
associated with a “benign evolution” of the infection [3]i n
which the ﬁbrosis plays a paramount role. Two patterns of
ﬁbrosis have been described in these lesions: a central one,
based on the production of a collagen matrix to organize
a small inert caseum, and a peripheral one, which is the
origin of the encapsulation and in which the ﬁbroblasts can
be easily identiﬁed, and related with the external cellular
ring, mostly composed by lymphocytes [3]. Usually, the
necrotic tissues of these primary lesions calcify, a fact that
has been used in studies aiming to detect infected subjects
and/or to evaluate the eﬀectiveness of BCG vaccination in
preventing the infection [4]. Interestingly, very few if any
calciﬁed lesions carry viable bacilli [5].
1.2. The Upper Lobes: the Scenario for Cavitation. Although
cavitationintheupperlobeshastraditionallybeenassociated
with reactivation of old lesions, this image has been found in
chest X-ray assay of both recently infected adults or in those
with a latent infection (LTBI) that suﬀered a reactivation
[6], thus highlighting the importance of this site in the
development of cavitation.
The clinical features observed in immunocompetent
adults are the combined result of mycobacterial replication
and a destructive host immune response [1]. Thus, the clas-
sical ﬁndings in chest radiography are upper lobe inﬁltrates
(60%) or cavitary lesions in the lung apex or upper zones
of the lower lobes (30–66%) [7], with most patients with2 Clinical and Developmental Immunology
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Figure 1: Interactions between the factors involved in the liquefaction process. The colour of the arrows shows the ability to induce a process
(in gray) or inhibit it (in red), and the thickness of the arrow is proportional to the intensity of this induction. The upper lobe appears to be
the sine qua non condition for the process to take place. Macrophage (MΦ) activation and the presence of CD4 is linked to the appearance
of diﬀerent cytokines with time: TNF initially, followed by IFN-γ and IL-4, and TGF-β from the onset and peaking at the chronic phase.
All those cytokines are proﬁbrotic (in violet) except for IFN-γ (in yellow). This site mainly undergoes a proﬁbrotic process although there
is also a nonspeciﬁc antiﬁbrotic eﬀect arising from the macrophages and their enzymatic activity. Extracellular bacilli also have antiﬁbrotic
activity and promote macrophage activation although they are also thought to inhibit such activation to some extent. Fibrosis prevents
liquefaction whereas liquefaction is promoted by macrophages, the immune response, by promoting the apoptosis of infected macrophages,
and extracellular bacilli. Liquefaction induces cavitation, inhibits macrophage activation (indeed, it appears to destroy them), and promotes
extracellular bacillary growth. Overall, liquefaction comes ﬁrst, and then the extracellular multiplication of bacilli occurs. Fibrosis, and thus
resume of the liquefaction, would occur only after the number of extracellular bacilli is reduced suﬃciently to allow attempts at healing to
take place. Finally, a large number of extracellular bacilli results in tissue destruction, cavity formation, and the death of the macrophages
that attempt to inhibit such bacillary growth.
pulmonary TB being observed to have multiple cavities [8]
with sizes ranging from between 1cm to more than 5cm
[9]. In contrast, severely immunosuppressed patients, such
as HIV positive patients with CD4 < 200mm3, the upper
lobe inﬁltrates and cavitation are reduced to 20% and 10%,
respectively [7].
1.3. Does the High Oxygen Pressure Favor Liquefaction? As
regards the tropism of cavity formation in the upper lobes,
it has been accepted since the 1940s that relative ischemia is
likely to aﬀect the apical localization of phthisis in humans.
Thus, the very low incidence of progressive apical lesions in
patients with mitral stenosis can be explained by the fact that
they have a higher pulmonary arterial pressure whereas the
very high incidence in patients with pulmonary stenosis is
due to the fact that they suﬀer a global ischemia in the lungs
[10].
Some years later, West [11] demonstrated that the blood
ﬂow in the lowermost pulmonary regions was up to 10 times
higher than in the uppermost regions whereas ventilation
was only 1.5-times higher, thus generating a progressive
fall in the ventilation-perfusion ratio of 3.3:0.63 from the
apex to the base. This generates large regional variations
in the alveolar partial pressures of oxygen, carbon dioxide,
and nitrogen, with a diﬀerence of 43, 15, and 29mm of
Hg, respectively, and therefore an increase of 41% and a
decrease of 39% and 5%, respectively, when compared with
the average values.
On the other hand, the diﬀerences as regards blood
gas content are much lower because of the shape of the
oxygen dissociation curve, the saturation (oxygen content)
falling by a 4%. In contrast, the slope of the carbon
dioxide dissociation curve varies by 7%, increasing the
pH to 7.5, a value outside the normal range for arterial
blood.Clinical and Developmental Immunology 3
All these factors suggest that the bacilli phagocytosed by
alveolar macrophages in the upper lobes will have a much
higher oxygen tension than those in the lower lobes, thereby
favoring their growth [12]. In contrast, the much lower
b l o o dﬂ o ww i l lr e d u c eb o t ht h en u m b e ro fc e l l st oc o m e
at the infectious foci and the quantity of bacilli drained
by the lymphatic system, thus reducing the immunological
surveillance. In addition, once a granuloma is set and local
inﬂammatory response is induced during the course of the
infection, the relative alkalosis will reduce the maturation
capacity of the dendritic cells, which is stimulated by acidic
pH(5.5–7.0),therebyalsorepressingthedevelopmentofTh1
immunity [13]( Table 1).
The impact of a high oxygen pressure in promoting TB
has been recently epidemiologically demonstrated by the
description of a lower TB incidence in a population living
at altitude (3000m) compared to another one with similar
socioeconomic status living at sea level [14].
On the other hand, the eﬀect of the ventilation gradient
is controversial: the weight of the lung itself can cause
some “sagging” within the thorax, the nondependent alveoli
being more expanded than the dependent alveoli, much
like a “slinky”, or coiled spring, hanging under its own
weight, where the upper coils are further apart than the
lower coils [15]. In contrast, some authors have reported
that gravity has only a minor eﬀect on pulmonary blood
ﬂow distribution and that two-thirds of the variability in
perfusion distribution is determined genetically [16]; this
fact could be used as a genetically driven susceptibility to
acquire TB.
Moreover, mechanical stress also needs to be considered,
as upper lobes have the highest values. Thus, in disease
states where the structural integrity of the lung is weakened,
mechanical failure occurs at this site. In practice, destruction
of parenchyma in centrilobular emphysema is most marked
n e a rt h ea p e x ,w i t hag r a d a t i o na sw em o v ed o w nt h e
lung. Rupture of a bleb on the upper lobe is almost always
the cause of spontaneous pneumothorax in an otherwise
healthy young patient [17]. As occurring in the upper lobes,
mechanical stress must have a relation with the induction of
cavitation (Table 1).
1.4.AreTuberculomastheConsequenceofaFailedLiquefaction
Process? A tuberculoma typically appears as a fairly discrete
nodule or mass in which repeated infection sites have
created a core of caseous necrosis surrounded by a mantle
of epithelioid cells and collagen with peripheral round-
cell inﬁltration. The majority of tuberculomas are less than
3cm in diameter although lesions up to 5cm have been
reported and tend to be mainly found in the upper lobes
[18]. Interestingly, both the tuberculomas and the cavitated
lesions shown a marked inﬂammatory response and a
high bacillary concentration, but the former having much
stronger vascularization and higher proliferative activity,
thus indicating a continuous local immune activity [19].
Moreover, tuberculomas and cavitated lesions are similar
in size [9, 18]. It has been suggested that the former could
be an intermediate phase between a controlled or “benign”
nodule and a cavitated lesion, with the only diﬀerence
between them being the liquefaction of the necrotic tissue.
Another hypothesis proposes that tuberculomas are actually
closed cavities [9].
2. The Liquefaction Process Has Only Been
StudiedinanExperimentalRabbitModel
Tuberculosis in rabbits has often been used as surrogate
modelforthestudyofthisdiseaseinhumans.Unfortunately,
the lack of appropriate reagents has led this model to
be considered obsolete by immunologists, and logistical
problems (i.e., housing and lack of inbred rabbits) have
resulted in it being poorly used and underexploited.
The systematic work undertaken by Dannenberg [20],
following in the steps of Lurie [21] and working with
relatively unsophisticated tools, has provided a great deal
of interesting information. The main breakthrough arose
as a result of breeding susceptible and resistant rabbit
strains(todaycommerciallyavailablerabbitsresembleLurie’s
resistant strains). Susceptible subjects experienced an earlier
increase in bacillary growth and also required a higher
bacillary load to trigger an adaptive immune response
than the resistant ones, developing in the lesions larger
necrosis but (contrary to what would be expected) without
liquefaction. This could be due to the fact that they died
before these events occurred, or because their macrophages
were less activated.
The authors hypothesized on the dichotomy between
delayed type hypersensitivity (DTH) and cell-mediated
immunity (CMI) to explain these diﬀerences in necrosis
induction.Theyconsideredthesusceptiblerabbitsdeveloped
a weak CMI, thus continuing using the tissue-damaging
immune response (necrotizing DTH) to stop the intra-
cellular bacillary multiplication. Then, the caseous center
enlarges, and local lung tissue is destroyed [20]. Eventually,
following infection with virulent bacilli, the susceptible
rabbits showed high DTH, because the virulent bacilli
reached higher titers in them and therefore provided a
larger antigenic stimulus. Nowadays, we know that the DTH
response is linked to CMI, being a local manifestation of
the arrival of speciﬁc lymphocytes attracted by the infected
macrophages or, in the case of the tuberculin skin test,
those that phagocyte tuberculin [22]. It has been argued
that the concentration of the antigens that elicit each is
diﬀerent: Protein Puriﬁed Derivative (PPD) elicits DTH
in very low concentrations whereas antigens eliciting CMI
probably need higher concentrations [20, 23]. On the other
hand, the role of speciﬁc immunity was clearly linked to
the liquefactionprocess whenYamamura etal. demonstrated
that desensitizing with tuberculin-active peptides protected
against induction of cavitations in rabbits [24]. This model
was also used to demonstrate the more intense the TST the
higher the number of cavitations, which was probably due
to the larger number of tubercle bacilli in these rabbits [25].
This fact correlates with clinical studies, which showed that
patients with larger TSTs were more apt to develop active TB
[26].4 Clinical and Developmental Immunology
This observation led to the concept that liquefac-
tion required the action of activated or strongly active
macrophages, a fact which can nowadays be compared to the
situation found in humans suﬀering from AIDS (see above),
who usually do not develop liquefaction and cavitation of
the lesions. These ﬁndings, therefore, link the action of
macrophages to the presence of a speciﬁc immune response.
Macrophage hydrolytic enzymes are thought to be
responsible for the liquefaction of tuberculous lesions [27].
However, although a number of such enzymes have been
identiﬁed to date, there is still no direct evidence to conﬁrm
that their activity is key to the development of liquefaction as
a natural progression of infection.
Finally,experimentsshowedthatkeepingM.tuberculosis-
infected rabbits erect in a harness for eleven hours each
day produced cavities in the upper lobes, resembling the
s i t u a t i o no b s e r v e di nh u m a n s[ 28].
3 .T h eM o us eM od elan dI t sF oc uso n
NecrosisFormation
Typically considered as a resistant host as it is able to survive
infectionforalongtime,nevertheless,themousemodeldoes
not usually develop liquefaction. In fact, we have postulated
thattheseanimalsaretolerantinsteadofresistant,astheycan
harbor a high bacillary concentration without hampering
their health status [29]. This can be related with their low
capacity to elicit a DTH against PPD, and thus its low
induction of intragranulomatous necrosis in this host [30].
Furthermore, the induction of intragranulomatous necrosis
in mice has been linked to the genetic background of the
animalalthoughthisnotprecludingabetterorworsecontrol
of the bacillary load, after low-dose aerosol infection. This
proposal was based on a comparison between mice with the
same H-2 background that develop necrosis but are either
more resistant (C57BL/6) or more susceptible (129/Sv) and
those that do not develop necrosis but are more resistant
(BALB/c) or more susceptible (DBA/2) to the infection [31].
Results showed that 129/Sv mice developed larger necrotic
lesions than C57BL/6 and that this was found to be linked to
a higher bacillary concentration in the lungs. Using the same
infection route, knocking out crucial cytokines or cell types
implicated in protection against infection did not prevent
the induction of necrosis. Rather, it increased the size of
the lesions if the knocking out was related to an increase
in the bacillary load [32]. Consolidation of the necrosis was
obtained by the chronic phase of the infection (i.e., week 6)
in all cases, a fact that could be linked to the accumulation of
foamy macrophages (FM), which have been postulated to be
the source of the intragranulomatous necrosis [33, 34].
FM have been also related to the drainage of nonrepli-
cating bacilli out from the granuloma through the alveolar
spaces, as demonstrated by Sk¨ old and Behar [35], therefore
supposed to be a source of constant endogenous reinfection,
a factor that has been suggested to be a way of maintaining
the Latent Tuberculosis Infection (LTBI) [36]. In this regard,
it can be claimed that the mice model is not a good one
to reproduce LTBI as it is seen in humans, because it is
thought that the main population of latent bacilli resides
in the intragranulomatous necrosis, and this phenomenon
is weak in mice. This is a controversial issue; as looking at
the necrosed tissue in humans [3] or big mammals [37], the
presence of bacilli is really very low if present. On the other
hand, chronic phase in murine TB has clearly demonstrated
the presence of a major population of latent bacilli [38, 39].
Indeed, data obtained in the mouse model and math-
ematically modulated [40] has shown how, at the onset
of infection, bacillary growth occurs in individual alveolar
macrophages, and that formation of granulomas is an
stochastic process that takes place once a critical number of
infectedmacrophagescoincidesinatimeandspatialmanner,
and is able to persist after becoming a local spot where
enough quantity of chemokines is produced and is stable
through time. Then, the granuloma is able to attract speciﬁc
or innate lymphocytes that would activate the infected
macrophages, thus being an important defensive structure
against M. tuberculosis infection, but that requires a constant
chemokine production to persist [41]. These particularities
in the onset of the infection provide an important window
for constant endogenous reinfection even in the presence of
protective immunity [40].
There is one mouse strain (C3HeB/FeJ) able to induce
liquefaction of the necrotic tissue, with diﬀerent outcomes
related to the control of the bacillary load [42]. Indeed, if the
infection is induced by a low-dose aerosol, this liquefaction
can be resumed, and the bacillary load is controlled (Vila-
plana et al., in preparation), thus showing an important fact,
which is that liquefaction is a reversible process, and thus
requires a maintenance whereas it persists, together with a
high bacillary load, if the infection is induced by a large dose
administered intravenously, causing the death of the animal
[42]. Liquefaction has also been observed in SCID mice
under certain conditions. Thus, if the animals are treated for
aperiodoftimewithchemotherapyafterinfectionbyaerosol
and the infection has been allowed to progress, the bacillary
load resumes its growth and leads to liquefaction after
suspension of the chemotherapy [43]. This phenomenon
can be explained as a result of the sudden and massive
resumption of growth in already infected macrophages,
which leads to the simultaneous necrosis of them and thus
to liquefaction due to an inability to ﬁbrose the necrosis
caused. This phenomenon, which we call the “synchronic
eﬀect” (Table 1), can help to explain the situation in
resistant rabbits and immunocompetent humans, where the
sudden onset of the immune response can induce a massive
apoptosis and/or necrosis of infected macrophages, thus
disturbing the balance of tissue organization and causing its
liquefaction. The reason why this does not usually happen
in immunocompetent mice could be due to its tolerant
response against M. tuberculosis infection, thus maybe even
when they accumulate a large bacillary concentration, it
does not accumulate locally, so the “synchronic eﬀect” does
not take place. However, it can explain why some severely
immunosuppressed patients develop liquefaction: they are
probably suﬀering from a large necrosis and thus more
chances for the synchronic of infected macrophages to take
place.Clinical and Developmental Immunology 5
Table 1: The factors involved in liquefaction.
(A) The upper lobes are privileged sites
(1) because of their low perfusion/ventilation ratio, which results in:
(a) an increase in bacillary growth inside individual alveolar macrophages due to the high oxygen pressure in the alveolar space,
(b) local alkalosis, and thus inhibition of dendritic cell maturation,
(c) decreased local perfusion, thus delaying the presentation of antigens at the local lymph nodes,
(2) the mechanical stress of ventilation makes stabilization of a ﬁbrotic lesion more diﬃcult.
(B) The ﬁbrinolytic ability of the macrophages.
(C) Immune response
( 1 )a sar e s u l to ft h es y n c h r o n i ce ﬀect, which provokes a massive apoptosis/necrosis of infected macrophages in a short period of time,
(2) induction of high levels of IFN-γ, which promotes ﬁbrinolysis,
(3) promotion of a massive entry of macrophages into the lesions.
(D) Extracellular bacillary accumulation
(1) the accumulation of plasminogen and its activation to plasmin induces ﬁbrinolysis and allows the maintenance of the liquefaction
through time,
(2) generation of a mantle of infected macrophages which maintains the inﬂammatory response.
Interestingly, the modeling of a Toxoplasma infection
in mice, which induces a strong Th1 response, has also
provided a further clue by highlighting the delicate balance
b e t w e e nT N Fa n dI F N - γ in the ﬁbrin deposits in the lesions,
with IFN-γ clearly favoring ﬁbrinolysis [44, 45], thus again
favouring the liquefaction process. This information must
be framed in time. It is demonstrated that at the beginning
of the M. tuberculosis infection, IL-1 and TNF are primary
cytokines that favor CMI, and thus the arrival of speciﬁc
l y m p h o c y t e sw h i c ha r ea b l et op r o d u c eI F N - γ, that activates
macrophages, so that they can inhibit the growth of tubercle
bacilli that they ingest. At the same time, it must be taken
into account that TGF-β is present from the very onset
of the infection, once macrophages phagocyte apoptotic
bodies [46], thus downregulating the CMI and favoring
the ﬁbrosis, an activity that increases its intensity as the
infection progresses, together with the presence of IL-4,
which has also been shown to be proﬁbrotic, which also
appears at latest time points [47] .T h i sp r o c e s si ss h o w n
in the Figure 1 and shows that liquefaction process, only
favored by the presence of IFN-γ is a process that has a very
small window to take place. It is also interesting to note the
downregulation induced by TNF to the IFN-γ activity which
might be a crucial factor to avoid liquefaction [48]. It can be
hypothesized that maybe this can be also behind the massive
induction of active TB in patients treated with anti-TNF
antibodies [49] not only because of the disorganization of
the granulomas but for the local increase of IFN-γ (without
the counterbalance of the TNF) that induces liquefaction.
4.Nonhuman Primates
The infection of nonhuman primates has also been shown to
produce cavities [23], but in a very diﬀerent manner when
compared to the rabbit model, even if probably reﬂecting
more accurately what happens in humans. Cavitation has
been detected as soon as seven weeks after the challenge or
later, at 28 weeks after infection although this phenomenon
has not been studied exhaustively to date [50], and it can be
eﬀectively avoided by BCG vaccination in Cynomolgus [51].
Furthermore, it has recently been reported that reactivation
of the infection occurs after the decrease in CD4 number
induced by the SIV virus, without causing cavitation in the
animals, thus resembling what happens in AIDS patients.
5. MinipigsHighlights the Role of Fibrosisin
Infection Control
Our search for a similarly sized animal to humans with
the same degree of intolerance to the bacilli [30]i nw h i c h
an experimental infection could be studied, led to the
development of the minipig experimental model. The key
point of interest for this model was to reproduce the classical
nonvisible lesions of LTBI in humans, qualiﬁed as “benign”
by Canetti [3]. The results showed two diﬀerent ﬁbrosis
patterns: an inner one, which is well organized due to the
inﬂuence of myoﬁbroblasts, and an outer one, which was
signiﬁcantly related to the contact with intralobular septae,
a structure not present in small mammals (including rabbits
and nonhuman primates) and that structure of the lung of
big mammals like minipigs (and also humans) [37]. These
ﬁbrotic patterns conﬁrmed their similarity with human
lesions according to Canetti’s descriptions in necropsies.
In this model, mature lesions with calciﬁcation appeared
very rapidly during progress of the infection (week 6 after
challenge). Cavitation has also been described in this host
[52], thus we do believe the model highlighting the role of
ﬁbrosis in the control of the infection, as with no proper
ﬁbrosis the liquefaction process occurs readily.
6. Do the Bacilli Themselves Interferein
the FibroticProcess?
It is well known that some components of the cell wall
of M. tuberculosis are able to bind to plasminogen and
even to transform it into plasmin, thereby inhibiting the
induction of ﬁbrosis [53]. Likewise, a study in Streptoccocus6 Clinical and Developmental Immunology
pyogenes showed that the ability to bind to ﬁbrin depends
on the speciﬁc mammal species concerned, thus it could
explain why M. bovis is less active against humans than M.
tuberculosis and vice versa for cows or goats [54]. However,
the role of the bacillary bulk is likely to be limited and
only relevant when a high extracellular concentration is
available in the necrotic and/or the liqueﬁed centre, in this
speciﬁc way of action, that is, by directly interfering to
the ﬁbrin production process. But this process might be
paramount for maintaining the liquefaction process and
avoiding its reversibility. On the other hand, it has been
demonstrated that M. tuberculosis speciﬁcally upregulates
matrixmetalloproteinase-1inhumanmacrophages(whereas
BCG vaccine does not) [55]. Excess of MMP activity in
the lung, therefore, results in collagen destruction, thus
favouring the liquefaction process (Table 1).
7. The Role of Architecture
T h ea l v e o l a rs p a c e si nh u m a n sa n dr a b b i t sa r em u c hl a r g e r
than in mice; therefore, this factor could also plays a role
in the healing process of the granulomatous lesion. Indeed,
it can be argued that the lung parenchyma, being denser
in mice, could exert a protective eﬀect by requiring less
intense ﬁbrosis to stabilize the granuloma than in humans
or rabbits. Eﬀectively, the volume of the alveolar space in
humans and rabbits is 57 and 8 times higher, respectively,
than in mice [56]. These data clearly show that rabbits and
humans must initiate a much faster and stronger ﬁbrotic
response than mice to stabilize the necrotic tissue generated
insideofthegranulomaandalsobecausethenecroticprocess
is much intense. This ﬁnding can also be linked to the higher
mechanical stress that suﬀers the upper lobes [17], which
interferes in building a ﬁbrotic structure to support the
lesion and also may favor liquefaction processes to take place
speciﬁcally in this site.
8. Towards a Holistic View of
Liquefaction Induction
Although the role of genetics has been accepted for many
years,researchintheareaofTBinductionhasmainlyfocused
on the deﬁciencies induced in the immunological response,
especially the Th1-Th2 balance, or nutritional elements that
favor mycobacterial growth, such as the availability of iron
or the lack of macrophage activation due to reduced levels
of vitamin D [57, 58]. Somewhat surprisingly, given the
fact that males suﬀer four times more incidence of active
disease than females, the inﬂuence of sex was not deﬁnitively
analyzed until recently [59]. This study suggested that this
diﬀerencecouldariseduetotheinﬂuenceofestrogensonthe
production of IFN-γ,o ri no t h e rw o r d s ,o ni m m u n o l o g i c a l
factors, as suggested years before [60]. However, the inﬂu-
ence of high ferritin concentrations in males, which favors
oxidative stress, thereby increasing macrophage activity and
possibly inducing ﬁbrinolysis, and thus reducing collagen
formation, or the inﬂuence of age, which results in increased
collagen breakdown and thus a decreased ﬁbrinogenic ability
[61], has received little attention.
9. What Can Be Done to Further
Prevent Liquefaction
Overall, the actual strategies to enhance the speciﬁc immune
response against M. tuberculosis appear to be still good.
If considering the dynamic hypothesis of LTBI, a strong
cellular immune response must help to control the constant
endogenous reinfection of the host. On the other hand,
the nature of this immune response (cellular type) leaves a
window that makes possible the constant reinfection process
[40]. This gives reasons for trying to build a better response
to avoid this window by building an eﬀectively protective
humoral response, which unfortunately appears to be very
diﬃcult although some results have been already obtained in
this ﬁeld [43, 62].
On the other hand, there is the process of induction
of tolerance to M. tuberculosis antigens, a strategy used for
a long time with tuberculins [63] that has proven to be
eﬀective in avoiding the liquefaction process, demonstrated
by Yamamura et al. experimentally [24]. In this regard,
it would be better to have more information about how
regulatory T cells behave and how they can be speciﬁcally
induced to have a more balanced immune response.
10. A New Model for Testing Inhibitorsof
Liquefaction in the Rabbit Skin
Recently,anewexperimentalmodelhasbeenvalidatedtotest
future drugs to inhibit liquefaction [27]. This test is based
in the induction of liquefaction in rabbit skin caused by the
inoculation of high bacillary load intradermally. The only
criticism that can be done is the fact that this phenomenon
takes place with another cellular type (i.e., the adypocytes),
and it might be diﬃcult to validate its correlation to what
it happens in the lungs, but on the other hand, it is a
reproducible and reliable test that will sure impulse the
knowledge in the ﬁeld and the research in new tools to avoid
the progression towards TB.
11. Summary: How Doesthe Progressionto
Liquefaction Occur?
Cavity formation has traditionally been considered to occur
from solid caseum, and a lot of controversies were raised to
understand who is the responsible of inducing liquefaction:
the reactivation of the bacilli trapped in the caseum of old
lesions or the macrophage through the extracellular release
of hydrolytic enzymes.
We understand liquefaction as one of the three possible
outcomes (the other two being control and dissemination)
of the constant endogenous reinfection process which would
maintain LTBI. This idea is supported by human-like
experimental models (i.e., the minipig model) suggesting
new lesions are constantly generated. The induction of a
higher number of new lesions would increase the probabilityClinical and Developmental Immunology 7
of one of them occurring in the appropriate location
to induce liquefaction as upper lobes. These lobes favor
higher bacillary load before the immune response appears
by directly promoting bacillary growth and delaying the
local onset of the immune response. Once this response
appears, however, the synchronized induction of apopto-
sis/necrosis of infected macrophages together with a high
IFN-γ concentration and the release of metalloproteinases
by new incoming macrophages would be critical factors to
promote the inhibition of localized ﬁbrosis of the lesion and
thus liquefaction. A high ability to generate a nonspeciﬁc
inﬂammatory response, which is structurally present in
males (i.e., high levels of ferritin), or a lower ability to
producecollagenwithage,couldhypotheticallypromotethis
liquefaction.
Although this process can be redirected with time, with
ﬁbrosis ﬁnally taking place, another, albeit slow factor,
namely extracellular bacillary growth, should be taken into
account. Such growth might be essential to allow the
irreversibility of the liquefaction process already triggered
due to the so-called bacillus factor, that is, ﬁbrinolytic
properties of proteins from the bacillary cell wall, or by
infecting the macrophages that surrounds the liquefaction,
and thus maintaining the Th1 response that favors lique-
faction to persist, whereby the presence of a large volume
of liquefaction product leads to the destruction of new
incoming macrophages (due to the high concentration of
free fatty acids [20]) and ﬁbroblasts, thereby preventing the
structuration of the site.
As conclusion, it could be said that liquefaction appears
to be a stochastic eﬀect due to disturbance in the orga-
nization of the intragranulomatous necrosis. The immune
response and its magnitude, the bacillary load, the speed
of the bacillary growth and the amount of extracellular
bacilli, as well as mechanic and chemical factors (due to the
distribution of the blood ﬂow) are involved in it. Animal
models have provided evidences to infer some of these
factors, but more eﬀorts on developing new models should
be done in order to better mimic the human disease.
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